MolDX: FANCC Genetic Testing Billing and Coding Guidelines – R1
February 12, 2019The MolDX: FANCC Genetic Testing Billing and Coding Guidelines coverage article has been revised and published for notice under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT) and 03602 (WY).
Summary of Changes: Added codes per the 2019 Annual CPT Code Update. Added Part A claim filing information.
- 81412 – ashkenazi jewish associated disorders (eg, bloom syndrome, canavan disease, cystic fibrosis, familial dysautonomia, fanconi anemia group c, gaucher disease, tay-sachs disease), genomic sequence analysis panel, must include sequencing of at least 9 genes, including aspa, blm, cftr, fancc, gba, hexa, ikbkap, mcoln1, and smpd1
- 81443 – genetic testing for severe inherited conditions (eg, cystic fibrosis, ashkenazi jewish-associated disorders [eg, bloom syndrome, canavan disease, fanconi anemia type c, mucolipidosis type vi, gaucher disease, tay-sachs disease], beta hemoglobinopathies, phenylketonuria, galactosemia), genomic sequence analysis panel, must include sequencing of at least 15 genes (eg, acadm, arsa, aspa, atp7b, bckdha, bckdhb, blm, cftr, dhcr7, fancc, g6pc, gaa, galt, gba, gbe1, hbb, hexa, ikbkap, mcoln1, pah)
Effective Date: January 1, 2019